We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$51.9M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$45.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.7M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$27.3M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBLN
5301
DELISTED
Babylon Holdings Limited
BBLN
$4K ﹤0.01%
36
-170
-83% -$22K
IDW
5302
DELISTED
IDW Media Holdings
IDW
$4K ﹤0.01%
2,346
+454
+24% +$918
BIOC
5303
DELISTED
Biocept, Inc.
BIOC
$4K ﹤0.01%
53
-14
-21% -$1.1K
TRAQ.U
5304
DELISTED
Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant
TRAQ.U
$4K ﹤0.01%
424
+24
+6% +$242
PEAR
5305
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$4K ﹤0.01%
728
-4,529
-86% -$20.6K
AGRX
5306
DELISTED
Agile Therapeutics
AGRX
$4K ﹤0.01%
10
+1
+11% +$638
AGFS
5307
DELISTED
AgroFresh Solutions Inc
AGFS
$4K ﹤0.01%
2,284
-3,015
-57% -$6.07K
MSDAU
5308
DELISTED
MSD Acquisition Corp. Unit
MSDAU
$4K ﹤0.01%
394
-349
-47% -$3.48K
CUEN
5309
DELISTED
Cuentas Inc. Common Stock
CUEN
$4K ﹤0.01%
244
-170
-41% -$2.62K
RUBY
5310
DELISTED
Rubius Therapeutics, Inc
RUBY
$4K ﹤0.01%
747
-8,670
-92% -$55.1K
ELVT
5311
DELISTED
Elevate Credit, Inc.
ELVT
$4K ﹤0.01%
1,340
-2,016
-60% -$6.34K
FTAAU
5312
DELISTED
FTAC Athena Acquisition Corp. Unit
FTAAU
$4K ﹤0.01%
393
– –
LGACU
5313
DELISTED
Lazard Growth Acquisition Corp. I Units
LGACU
$4K ﹤0.01%
387
-208
-35% -$2.05K
SJIV
5314
DELISTED
South Jersey Industries, Inc. Corporate Units
SJIV
$4K ﹤0.01%
+59
New +$3.57K
GSQD
5315
DELISTED
G Squared Ascend I Inc.
GSQD
$4K ﹤0.01%
436
-769
-64% -$7.59K
HZN
5316
DELISTED
Horizon Global Corporation
HZN
$4K ﹤0.01%
673
-1,396
-67% -$8.93K
AHPI
5317
DELISTED
Allied Healthcare Products
AHPI
$4K ﹤0.01%
+1,228
New +$4.33K
PRBM
5318
DELISTED
Parabellum Acquisition Corp.
PRBM
$4K ﹤0.01%
444
+377
+563% +$3.69K
DNZ
5319
DELISTED
D and Z Media Acquisition Corp.
DNZ
$4K ﹤0.01%
405
– –
SVFA
5320
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$4K ﹤0.01%
397
-564
-59% -$5.54K
GACQ
5321
DELISTED
Global Consumer Acquisition Corp. Common Stock
GACQ
$4K ﹤0.01%
426
-2,346
-85% -$23.4K
HIIIU
5322
DELISTED
Hudson Executive Investment Corp. III Unit
HIIIU
$4K ﹤0.01%
413
-1
-0.2% -$10
GSEV
5323
DELISTED
Gores Holdings VII, Inc. Class A Common Stock
GSEV
$4K ﹤0.01%
395
-2,796
-88% -$27.3K
ZWRKU
5324
DELISTED
Z-Work Acquisition Corp. Units
ZWRKU
$4K ﹤0.01%
412
– –
CRU
5325
DELISTED
Crucible Acquisition Corporation
CRU
$4K ﹤0.01%
406
+388
+2,156% +$3.79K
211 212
213
214 215

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.